(Q77366765)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Pathologic parameters in the diagnosis and prognosis of primary cutaneous melanoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

H R Byers

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 August 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

Hematology / Oncology Clinics of North America

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

717-735

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

Malignant melanoma: a unifying concept

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Discordance among expert pathologists in diagnosis of melanocytic neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Focal adhesion kinase (p125FAK) expression correlates with motility of human melanoma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Mel-5: a novel antibody for differential diagnosis of epidermal pigmented lesions of the skin in paraffin-embedded sections.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Thin malignant melanomas (less than 1.5 mm) with metastasis: a histological study and survival analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Actin-binding protein expression in benign and malignant melanocytic proliferations

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

The eortc melanoma group exchange program: Evaluation of a multicenter monoclonal antibody study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Model predicting survival in stage I melanoma based on tumor progression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Histopathologic diagnosis of dysplastic nevi: Concordance among pathologists convened by the world health organization melanoma programme

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Actin-binding protein requirement for cortical stability and efficient locomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Melanoma cell heterogeneity. A study of two monoclonal antibodies compared with s-100 protein in paraffin sections

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Vascular invasion in malignant melanomas. An independent prognostic variable?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Discordance in the histopathologic diagnosis of melanoma and melanocytic nevi between expert pathologists

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Cellular tumorigenicity in nude mice: correlation with cell growth in semi-solid medium.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

S100 protein is present in cultured human malignant melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Radiation therapy for malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

High risk of malignant melanoma in melanoma-prone families with dysplastic nevi

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Malignant melanoma. Primary surgical management (excision and node dissection) based on pathology and staging

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

"Microscopic satellites" are more highly associated with regional lymph node metastases than is primary melanoma thickness

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Inter-observer variation between pathologists in the classification of cutaneous malignant melanoma in western Australia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Histologic regression in malignant melanoma: an interobserver concordance study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

p75 nerve growth factor receptor staining helps identify desmoplastic and neurotropic melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Peripheral blood tyrosinase messenger RNA detection and survival in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Functional characterization of T lymphocytes propagated from human lung carcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

The Prognostic Implications of Microscopic Satellites in Patients With Clinical Stage I Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Correlation of growth capacity of human tumor cells in hard agarose with their in vivo proliferative capacity at specific metastatic sites

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

In situ expression of transforming growth factor ?? is associated with melanoma progression and correlates with Ki67, HLA-DR and ?? 3 integrin expression

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Comparison of HMB-45 monoclonal antibody and S-100 protein in the immunohistochemical diagnosis of melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Cell proliferation markers in predicting metastases in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Recent advances in the care of the patient with malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Prognostic histopathological factors in malignant melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Cutaneous melanoma: pathology, relevant prognostic indicators and progression.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Predicting survival and recurrence in localized melanoma: a multivariate approach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Lentigo maligna of the head and neck. Results of treatment by radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Thin stage I primary cutaneous malignant melanoma. Comparison of excision with margins of 1 or 3 cm.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Recognition of malignant melanoma by monoclonal antibody HMB-45. An immunohistochemical study of 200 paraffin-embedded cutaneous tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

Pathologic prognostic factors for cutaneous malignant melanoma: the Western Canada Melanoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970020-4

7 January 2021

10.1016/S0889-8588(05)70020-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9759576%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference